V. M. Polonskii
|
|
M.B. Anciferov, L.G. Dorofeeva
Vildagliptin - A New Dipeptidylpeptidase-4 Inhibitor For The Treatment Of Type 2 Diabetes Mellitus
|
12-16 |
M.B. Anciferov, L.G. Dorofeeva
Prospects Of The First Human Glucagon-like Peptide 1 Analog Liraglutid Use In The Treatment Of Patients With Type 2 Diabetes Mellitus
|
17-23 |
T.Yu. Berketova
Peculiarities Of Course And Treatment Of Thyroid Diseases In Women Peri-and Postmenopausal Period
|
24-31 |
M.B. Anciferov, O.M. Koteshkova, V.V. Sitnikov, O.A. Mityaeva, L.P. Pashinceva, T.A. Budanceva, E.A. Ivanova
Experience Of Incritinomimetic Exenatide (byetta) Use In The Treatment Of Patients With Type 2 Diabetes Mellitus With Obesity
|
32-37 |
A.V. Zilov
Metformin - Pathogenetic Drug Of First-line In The Treatment Of Type 2 Diabetes
|
38-42 |
V.V. Privolnev
Diabetic Foot Syndrome: Approaches To Treatment Of Infection
|
43-47 |
N.A. Strebkova, N.V. Udalova
Cushing's Basophilism In Children And Adolescents
|
48-52 |
V.A. Peterkova, T.A. Klimenko
Screening For Congenital Hypothyroidism In Russia
|
54-58 |
A.M. Mkrtumyan
Do All We Know About The Thiazolidinediones, Or What Pioglitazone Differs From Rosiglitazone?
|
60-64 |
M.B. Anciferov, E.V. Petraneva
Possibilities Of Insulin Glargine (lantus ®) Use For Treatment Of Type 2 Diabetes Mellitus In The Outpatient Endocrinology Services: An Analysis Of The Register Laurel
|
65-69 |
E.E. Petryaikina, O.V. Duchareva, I.G. Ryibkina, E.A. Pronina, T.D. Michailova, I.V. Garyaeva, E.T. Mandjieva
Insulin Pump Therapy - A Way To Achieve Clinical And Metabolic Compensation Of The Disease In Children And Adolescents With Type 1 Diabetes Mellitus
|
70-75 |
L.A. Kapustina, O.S. Nesterova, A.N. Boiko, I.D. Stulin, M.B. Anciferov
Effect Of Alpha-lipoic Acid (tiogamma) On The Quality Of Life Of Patients With Diabetic Peripheral Polyneuropathy
|
76-81 |
I.M. Ischenko, T.M. Milenkaya
The Effectiveness Of The Drug Vessel Due F In Patients With Diabetes With Nonproliferative And Preproliferative Diabetic Retinopathy
|
82-86 |